Oncotelic Therapeutics, Inc. (OTLC) Shareholders’ equity 2013–2024
Oncotelic Therapeutics, Inc. (OTLC) shareholders’ equity at each fiscal year-end, per SEC filings.
$12.1MFY2024 · since FY2013: $4.5M → $12.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $12.1M | — |
| FY2021 | $11.8M | — |
| FY2014 | $6.0M | +32.9% |
| FY2013 | $4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice